Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A hemangioma characterized by the presence of cavernous vascular spaces.
Biomarker and diagnostic research for cavernous hemangioma has been reported in the published literature.
7 clinical trials registered, 3 recruiting. Interventions under study include other interventions, medical devices, and procedural interventions. Pipeline includes 3 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT05477680](https://clinicaltrials.gov/study/NCT05477680) |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 11:07 AM UTC
Intraoperative Brain Shift Calculation Study
NA |
Sklifosovsky Institute of Emergency Care |
RECRUITING |
[NCT05484245](https://clinicaltrials.gov/study/NCT05484245) | Sonography-guided Resection of Brain Mass Lesions | NA | Sklifosovsky Institute of Emergency Care | RECRUITING |
[NCT04076449](https://clinicaltrials.gov/study/NCT04076449) | Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy | — | yuanli Zhao | RECRUITING |
[NCT01764529](https://clinicaltrials.gov/study/NCT01764529) | Modifiers of Disease Severity in Cerebral Cavernous Malformations | — | University of California, San Francisco | UNKNOWN |
[NCT04467489](https://clinicaltrials.gov/study/NCT04467489) | Biomarkers of CASH | — | University of Chicago | ACTIVE_NOT_RECRUITING |
321 publications have been identified in PubMed for cavernous hemangioma. Kisho has analyzed 171 by research type. Research spans Case Report / Case Series (31%), Review / Meta-Analysis (25%), and Basic Science / Preclinical (12%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 53 | 31% |
Research summaries | 43 | 25% |
Laboratory research | 21 | 12% |
Disease patterns and progression | 21 | 12% |
Clinical study results | 15 | 9% |
Testing and diagnosis research | 11 | 6% |
Other research | 4 | 2% |
New treatment approaches | 3 | 2% |
Li L (2026). [PMID: 41891922](https://pubmed.ncbi.nlm.nih.gov/41891922/). *J Exp Med*. [Basic Science / Preclinical]
Baizabal-Carvallo JF (2026). [PMID: 41628579](https://pubmed.ncbi.nlm.nih.gov/41628579/). *J Neurol Sci*. [Review / Meta-Analysis]
Fontes-Dantas FL (2026). [PMID: 41486746](https://pubmed.ncbi.nlm.nih.gov/41486746/). *J Neurochem*. [Review / Meta-Analysis]
Zhang Y (2026). [PMID: 41637276](https://pubmed.ncbi.nlm.nih.gov/41637276/). *Eur J Ophthalmol*. [Review / Meta-Analysis]
Kim S (2026). [PMID: 41576376](https://pubmed.ncbi.nlm.nih.gov/41576376/). *J Neurosurg Spine*. [Diagnostic / Biomarker]
Dai Z (2026). [PMID: 41938137](https://pubmed.ncbi.nlm.nih.gov/41938137/). *Mater Today Bio*. [Gene Therapy / Novel Therapeutics]
Planet M (2026). [PMID: 41043184](https://pubmed.ncbi.nlm.nih.gov/41043184/). *J Neurosurg*. [Basic Science / Preclinical]
Uslu I (2026). [PMID: 42252346](https://pubmed.ncbi.nlm.nih.gov/42252346/). *Neurosurg Rev*. [Review / Meta-Analysis]
Al-Ani A (2026). [PMID: 41912036](https://pubmed.ncbi.nlm.nih.gov/41912036/). *Can J Ophthalmol*. [Case Report / Case Series]
Landa-Garmendia M (2026). [PMID: 41864506](https://pubmed.ncbi.nlm.nih.gov/41864506/). *Acta Otorrinolaringol Esp (Engl Ed)*. [Review / Meta-Analysis]